About
Inflammation Modification
Areas of Focus
Categories
Small Molecule PharmaceuticalNorth & South Carolina
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
663
By Phase
PHASE2: 3PHASE1: 1
By Status
COMPLETED: 4
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details
Recent Trials
NCT04610047Lead Sponsor
Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness
PHASE2Completed
315 participants
Started: Dec 14, 2020 · Completed: Feb 9, 2022
NCT04043923Lead Sponsor
Norketotifen for the Treatment of Uncomplicated Influenza-like Illness
PHASE2Completed
238 participants
Started: Oct 21, 2019 · Completed: Apr 20, 2020
NCT03887026Lead Sponsor
Efficacy and Safety of Norketotifen in Adults With Allergic Rhinitis
PHASE2Completed
36 participants
Started: Apr 1, 2019 · Completed: May 29, 2019
NCT03712163Lead Sponsor
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Norketotifen in Healthy Subjects
PHASE1Completed
74 participants
Started: Oct 15, 2018 · Completed: Mar 14, 2019
Locations (1)
Headquarters
Durham, NC, United States
Map
Loading map...